Atai Life Sciences
ATAI is an internationally active biotech company investing in and acquiring therapeutics focusing on longevity and mental wellbeing.
Atai Life Sciences has raised €273M across 3 funding rounds from 4 investors, most recently a Series D+ round in Mar 2021. Based in Munich, Germany; founded 2018; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€273M
€273,452,988
Funding rounds
3
Investors
4
distinct backers
Active since
2019-01
latest 2021-03
Funding by year
EUR raised per yearAtai Life Sciences — funding by year — interactive chart.
Data table
| Atai Life Sciences — funding by year | |
|---|---|
| 2018 | €38M |
| 2020 | €105M |
| 2021 | €131M |
Signals
High confidenceRaise-next likelihood11
base rate 53% for Series D+
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood14
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▲ 8y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-03-03 | Series D+ | €131M | Apeiron Investment Group,Thiel Capital,Woodline Partners | View deal → |
| 2020-11-23 | Series C | €105M | — | View deal → |
| 2019-01-01 | Series B | €38M | Subversive Capital | View deal → |
Related news
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData